| |
|
|
|
Avadel Pharmaceuticals Plc ADR  
|
|
9.86 1.74 (0.21%) |
09-28 16:00 |
|
Open: |
9.78 |
Pre close: |
8.12 |
Target:
|
12.54 
|
|
High: |
10.74 |
Low: |
9.5236 |
Resistance:
|
10.74
12.54
|
|
Volume: |
972,516 |
Market Cap: |
577M |
Support:
|
8.89
7.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.25
|
MACD |
MACD(12,26):
|
0.39 |
|
MA(20): |
8.33 |
Signal(12,26,9): |
0.19 |
|
MA(100): |
7.77 |
Stochastic Oscillator |
%K(14,3):
|
82.48  |
|
MA(250): |
7.51 |
%D(3): |
81.06 |
|
Average Volume(K) |
3-Month: |
880285
|
52-Week |
High:
|
10.74 |
|
10-Days: |
61267 |
Low: |
4.90 |
|
RSI |
RSI(14):
|
79.44 |
Change(%): |
95.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.100 |
Return on Equity (ttm) |
-37.2 |
Shares Out. (M) |
58.49 |
|
EPS Est. Current Year |
1.160 |
Return on Assets (ttm) |
-13.0 |
Shares Float (M) |
44.78 |
|
EPS Est. Next Year |
0.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.07 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
57.78 |
|
Forward EPS |
-0.890 |
Gross Profit (p.s.) |
0.284 |
Shares Short (K) |
3640 |
|
Book Value (p.s.) |
2.330 |
EBITDA (p.s.) |
-1.093 |
P/E |
-98.60 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.23 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-62.88 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-35.64 |
P/CF |
-9.17 |
|
|
|
|
|
|
